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Abstract: Conventional two-dimensional (2D) cell cultures are grown on rigid plastic substrates
with unrealistic concentration gradients of O2, nutrients, and treatment agents. More importantly,
2D cultures lack cell–cell and cell–extracellular matrix (ECM) interactions, which are critical for
regulating cell behavior and functions. There are several three-dimensional (3D) cell culture systems
such as Matrigel, hydrogels, micropatterned plates, and hanging drop that overcome these drawbacks
but they suffer from technical challenges including long spheroid formation times, difficult handling
for high throughput assays, and/or matrix contamination for metabolic studies. Magnetic 3D
bioprinting (M3DB) can circumvent these issues by utilizing nanoparticles that enable spheroid
formation and growth via magnetizing cells. M3DB spheroids have been shown to emulate tissue
and tumor microenvironments while exhibiting higher resistance to toxic agents than their 2D
counterparts. It is, however, unclear if and how such 3D systems impact cellular metabolic networks,
which may determine altered toxic responses in cells. We employed a Stable Isotope-Resolved
Metabolomics (SIRM) approach with 13C6-glucose as tracer to map central metabolic networks both
in 2D cells and M3DB spheroids formed from lung (A549) and pancreatic (PANC1) adenocarcinoma
cells without or with an anti-cancer agent (sodium selenite). We found that the extent of 13C-label
incorporation into metabolites of glycolysis, the Krebs cycle, the pentose phosphate pathway, and
purine/pyrimidine nucleotide synthesis was largely comparable between 2D and M3DB culture
systems for both cell lines. The exceptions were the reduced capacity for de novo synthesis of
pyrimidine and sugar nucleotides in M3DB than 2D cultures of A549 and PANC1 cells as well as the
presence of gluconeogenic activity in M3DB spheroids of PANC1 cells but not in the 2D counterpart.
More strikingly, selenite induced much less perturbation of these pathways in the spheroids relative
to the 2D counterparts in both cell lines, which is consistent with the corresponding lesser effects on
morphology and growth. Thus, the increased resistance of cancer cell spheroids to selenite may be
linked to the reduced capacity of selenite to perturb these metabolic pathways necessary for growth
and survival.
Keywords: selenite; cancer metabolism; A549; PANC1; 13C6-glucose tracer; 2D cell cultures;
3D spheroids
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1. Introduction
It is now clear that mammalian cells grown as two-dimensional (2D) cultures on rigid and
treated surfaces may exhibit different behavior and functional properties (such as drug sensitivity)
from those in the native microenvironment or in three dimensional (3D) cultures i.e., spheroids and
organoids [1–4]. This could be attributable to the lack of cell–cell and cell–extracellular matrix (ECM)
interactions as well as the unrealistic gradients of O2, nutrients, growth factors, and treatment agents
in 2D cultures [1]. Three-dimensional spheroids are self-assembled compact aggregates of single
cell types to enable extensive cell–cell and cell–ECM interactions, whereas 3D organoids add the
interactions with other cell types [3,5]. They can circumvent the drawbacks of 2D cell cultures in
terms of ECM formation, cell–cell interactions, and physicochemical environment. Spheroids can be
generated from mono-cultures spontaneously or in an appropriate matrix such as Matrigel, collagen,
hyaluronan, or synthetic polyethylene glycol [5–10], while organoids are typically formed from live
tissues or multiple cell types in Matrigel or collagen [5,9,11–13]. Both spheroids and organoids more
closely mimic the natural tissue organization than 2D cultures, while retaining similar experimental
flexibility [10,14]. They have been shown to display altered gene expression profiles including those
metabolism-related, nutrient oxidation capacity, metastatic capacity induced by proline catabolism,
O2 consumption/extracellular acidification, and drug response compared with the 2D cell culture
counterparts [1,3,4,7,15–18]. However, our knowledge is still very limited regarding the functional or
metabolic mechanisms underlying these differences.
Although multiple scaffolds (e.g., Matrigel, hydrogel) or scaffold-free (hanging drop,
micropatterned/U-shape cell-repellent plates) 3D cell culture systems have been developed for
culturing cancer cell spheroids [3,5,19], they suffer from technical challenges such as long spheroid
formation times with variable efficiency and/or difficult handling for high throughput assays [1].
For metabolomic studies, there are added problems of matrix contamination and/or limitations in
scaling-up. Magnetic 3D bioprinting (M3DB), a more recent development in 3D culture system,
can overcome these difficulties. This technique utilizes nanoparticles composed of gold, iron
oxide, and poly-L-lysine to magnetize cells, followed by spheroid assembly under mild magnetic
forces [1]. Spheroids are formed reproducibly within minutes to hours in cell repellent plates and
are biocompatible for various functional assays including toxicity testing [1,20–26]. This matrix-free
method is particularly amenable for Stable Isotope-Resolved Metabolomic (SIRM) studies [2,27–37]
as securing spheroids with magnets enables rapid tracer medium change, sampling at different time
points or removal during metabolic quenching. Here, we demonstrate the utility of coupling the M3DB
culturing with SIRM in exploring the metabolic mechanism that underlies the increased resistance
to anti-cancer sodium selenite in 3D spheroids formed from lung (A549) and pancreatic (PANC1)
adenocarcinoma cells versus their 2D cell counterparts.
2. Results
2.1. Three-Dimensional A549 and PANC1 Spheroids Are More Resistant to Selenite Than Their 2D Cell Counterparts
We have shown previously that sodium selenite (a chemopreventive agent [38,39]) is toxic to
A549 cells in 2D cultures with 24 h IC50 (half maximal inhibitory concentration) at 6.25 µM [40].
Here we determined the 26 h IC50 of selenite in 2D PANC1 cells to be 10 µM. We also investigated
the dose-dependent effect of selenite on the growth of A549 and PANC1 M3DB spheroids. As shown
in Figure 1A, selenite had a complex effect on the growth of both spheroid types after 1- and 2-day
of treatment. There appeared to be at least two populations of cells with one more resistant than the
other. The IC50 for neither population could be determined after 1-day treatment. In addition, at doses
≤50 µM, selenite slightly stimulated the overall growth of both spheroid types at 1-day, but not 2-day,
of treatment. However, selenite inhibited the growth (Figure 1A) and disrupted spheroid structures
(Figure 1B) of both sensitive and resistant populations alike after 3 days of treatment. The complexity of
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the dose-dependence curves made it difficult to estimate the IC50 for the 1-day treatment. We were able
to determine the IC50 for the sensitive A549 spheroids as 16.7 µM at 3-day and PANC1 spheroids as
9.4 and 13.7 µM at 2- and 3-day, respectively (Table 1). The 2-day IC50 for the sensitive A549 spheroids
was estimated at 46 µM, which was not as well defined due to insufficient points in the dose-response
curve. Suffice to say, the spheroid cultures of A549 and PANC1 cells displayed overall less growth
inhibition than the 2D counterparts.
In addition, we measured the ROS production as a function of time and selenite dose in A549 and
PANC1 spheroids, as shown in Figure 1C. Selenite induced a burst of ROS production at 10–20 µM
after 1 day of treatment in both A549 and PANC1 spheroids. This burst persisted, albeit to a lower
extent, for up to 3 days of treatment in A549 but not in PANC1 spheroids. In addition, ROS production
did not commensurate with growth inhibition in A549 spheroids but appeared to be related to reduced
growth and/or cell death in PANC1 spheroids after 3 days of treatment. Based on these data, we chose
24 h of 10 µM selenite treatment, which gave a burst of ROS in both spheroid types, in subsequent
13C6-glucose-based SIRM experiments on the spheroid cultures. The results were compared with those
obtained from the 2D culture experiments performed with IC50 doses of selenite, i.e., 6.25 µM for A549
and 10 µM for PANC1 cells. This design should maximize differential metabolic responses between
spheroid (with the resistant cell population presumably unaffected) and 2D cell cultures.
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Table 1. IC50 of selenite for A549 and PANC1 spheroids after 2 and 3 days of treatment. 
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a Percentage of the sensitive cell population (cf. Figure 1A); b not well-determined. 
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Figure 1. Dose- and time-dependent growth inhibition and ROS production of A549 and PANC1
spheroids by selenite. A549 or PANC1 spheroids were formed, cultured, and assayed for growth
using a live cell stain PrestoBlue i 384-well plate as described in Materials n Method. The slope
of the time-depende t redu tion of PrestoBlue was calculated for e ch well, averaged, and plotted
as a function of selenite concentrations in (A); n = 5 per treatment. These data were used to estimate
IC50 and percentage of sensitive cell population in Table 1 by data fitting (see Materials and Methods).
In (B), example images (10×magnification) of spheroids after 3 days of 0 or 50 µM selenite treatment.
Scale bars are 400 µm. In (C), time- and selenite dose-dependent production of reactive oxygen
species (ROS) by A549 and PANC1 spheroids was measured by dichlorofluoroscein (DCF) fluorescence.
n = 3 per data point.
Table 1. IC50 of selenite for A549 and PANC1 spheroids after 2 and 3 days of treatment.
Spheroids Treatment Days IC50 (µM) % Sensitive a R2
A549 2 (46) b 53 0.997
A549 3 16.7 ± 0.6 81 0.998
PANC1 2 9.4 ± 0.2 32 0.999
PANC1 3 13.7 ± 0.9 92 0.995
a Percentage of the sensitive cell population (cf. Figure 1A); b not well-determined.
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2.2. The Higher Selenite Resistance of 3D A549 and PANC1 Spheroids Is Not Due to Less Se Accumulation
Than the 2D Counterparts
One immediate question about the higher selenite resistance in the 3D spheroids was if this is
due to less Se accumulation in their biomass than that of the corresponding 2D cells. To address this
question, we performed parallel selenite treatments of A549 and PANC1 cells as 2D and 3D spheroid
cultures for total Se analysis by ICP-MS. We found that total Se in 3D spheroids were higher than
that in 2D cultures for both A549 and PANC1 cells (sum, Figure S1). The higher Se accumulation
in 3D biomass was a result of elevated selenite uptake from the media for A549 cells but not for
PANC1 cells (medium uptake, Figure S3). The latter suggests enhanced loss of absorbed selenite via
volatilization [41] in 2D over 3D PANC1 cells. By analyzing Se in polar extracts, protein extracts, and
residue (after polar and protein extractions) of A549 and PANC1 cells, we found that the Se content
followed the order residue > protein > polar fractions for both 2D and 3D cultures. It is interesting
to note that Se was enriched relatively more in the soluble (polar and protein) fractions of 2D than
3D cultures for both A549 and PANC1 cells. It is possible that some form(s) of Se in these fractions
contribute to higher toxicity in the 2D cell cultures [40]. In any rate, there was no straightforward
relationship between selenite uptake and observed differences in 2D and 3D cell toxicity.
2.3. Glycolysis and the Krebs Cycle Respond Less to Selenite in A549 and PANC1 Spheroids than in Their 2D
Cell Counterparts
In SIRM experiments, 6.25 µM selenite attenuated net growth and induced morphological changes
in A549 cells grown in 2D cultures (Figure S2A). Such changes were less evident in the corresponding
3D spheroids at 10 µM selenite (Figure S2B). Likewise, 10 µM selenite elicited greater perturbations in
morphology and proliferation in 2D (Figure S3A) than 3D cell cultures of PANC1 (Figure S3B), which
is consistent with the presence of a higher population of resistant cells in spheroid than in 2D cell
cultures, as described above. Consistent with the PrestoBlue assay for growth (Figure 1A), the mitotic
index (as indicated by the PCNA fluorescence) was reduced by 3 days of 100 µM selenite treatment
in both A549 and PANC1 spheroids. The growth inhibition was accompanied by increased necrosis
(as indicated by the RIP-1 fluorescence) in both A549 and PANC1 spheroids (Figure S2).
These phenotypic differences were accompanied by differential metabolic responses to selenite
between 2D cell and 3D spheroid cultures. Figure 2 compares the extent of 13C6-glucose (13C6-Glc)
transformation through glycolysis and the Krebs cycle between A549 in 2D culture and as spheroids in
response to 24 h of selenite treatments at 6.25 µM and 10 µM, respectively. Significant perturbations
to the glycolytic activity were evident in selenite-treated 2D cells based on the enhanced release
of 13C3-lactate into the medium (Figure 2(I-D)) and lower fractional enrichment in intracellular
13C3-pyruvate (3; Figure 2(I-B)). In contrast, there was no effect of selenite on 13C3-pyruvate
(Figure 2(II-B)) and the stimulation of 13C3-lactate release was relatively lower from spheroid cultures
(Figure 2(II-D)) than from 2D cultures (Figure 2(I-D)); indicating a lesser perturbation of selenite to
glycolysis in spheroids than in 2D cells. Likewise, the selenite-induced changes in the Krebs cycle was
also much less in spheroids than in 2D cells, as evidenced by the much reduced perturbation to the
extent of 13C incorporation into the Krebs cycle metabolites, including citrate and α-ketoglutarate (αKG)
(Figure 2(II-E,II-F) versus Figure 2(I-E,I-F), respectively). In particular, the fractional enrichment of
13C4- (red boxes) and 13C3-citrate (green boxes) showed prominent differences between the two culture
types (Figure 2(I-E,II-E)). As 13C4-citrate is a marker of pyruvate dehydrogenase (PDH)-initiated
Krebs cycle activity [42] while 13C3-citrate results from pyruvate carboxylase (PCB)-initiated Krebs
cycle reactions [34], these differences suggest a differential effect of selenite on both canonical and
anaplerotic Krebs cycle activities in A549 spheroids versus 2D cells. Other prominent differences in the
selenite effect on the two culture types involved Glu and GSH metabolism. The extent of enrichment
in 13C2-Glu and -GSH (red boxes; Figure 2(I-I,I-J,II-I,II-J)) was much less attenuated in spheroids
than in 2D cells. The 13C atom-resolved tracing shown in Figure 2 (
Metabolites 2018, 8, x 4 of 16 
 
2.2. The Higher Selenite Resistance of 3D A549 and PANC1 Spheroids Is Not Due to Less Se Accumulation 
Than the 2D Counterparts 
One immedi te question about the higher selenite r sistance in the 3D spheroids was if this is 
due to less Se accumulation in their biomass than that of the corresponding 2D cells. To address this 
question, we performed parallel selenite treatments of A549 and PANC1 cells as 2D and 3D spheroid 
cultures for total Se analysis by ICP-MS. We found that total Se in 3D spheroids were higher than 
that in 2D cultures for both A549 and PANC1 cells (sum, Figure S1). The higher Se accumulation in 
3D biomass was a result of elevated selenite uptake from the media for A549 cells but not for PANC1 
cells (medium uptake, Figure S3). The latter suggests enhanced loss of absorbed selenite via 
volatilization [41] in 2D over 3D PANC1 cells. By analyzing Se in polar extracts, protein extracts, and 
residue (after polar and protein extractions) of A549 and PANC1 cells, we found that the Se content 
followed the order residue > protein > polar fractions for both 2D and 3D cultures. It is interesting to 
note that Se was enriched relatively more in the soluble (polar and protein) fractions of 2D than 3D 
cultures for both A549 and PANC1 cells. It is possible that some form(s) of Se in these fractions 
contribute to higher toxicity in the 2D cell cultures [40]. In any rate, there was no straightforward 
relationship between selenite uptake and observed differences in 2D and 3D cell toxicity. 
2.3. Glycolysis and the Krebs Cycle Respond Less to Selenite in A549 and PANC1 Spheroids than in Their 2D 
Cell Counterparts 
In SIRM experiments, 6.25 µM selenite attenuated net growth and induced morphological 
changes in A549 cells grown in 2D cultures (Figure S2A). Such changes were less evident in the 
correspondi g 3D spheroids at 10 µM selenite (Figure S2B). Likewise, 10 µM selenite elicited greater 
perturbations in morphology and proliferation in 2D (Figure S3A) tha  3D cell cultures of PANC1 
(Figure S3B), which is consistent with the presence of a higher population of resistant cells in 
spheroid than in 2D cell cultures, as d cribed above. Consistent wit  the PrestoBlue assay for 
growth (Figur  1A), the mitotic index (as indicated by the PCNA fluorescence) was reduced by 3 
days of 100 µM selenite treatm nt in both A549 and PANC1 spheroids. The growth inhibition was 
accompanied by incre ed necrosis (as indicated by th  RIP-1 fluorescence) in both A549 and 
PANC1 pheroids (Figure S2). 
Th se phenotypic differences were accompanied by differential metabolic responses to selenite 
between 2D cell and 3D spheroid cultures. Figure 2 compares the xtent of 13C6-glucose (13C6-Glc) 
transforma ion through glycolysis and the Krebs cycle between A549 in 2D culture and as spheroids 
in response to 24 h of selenite treatments at 6.25 µM and 10 µM, respectively. Significant 
perturbations to the glycolytic activity were evident i  s lenite- reated 2D cells based on the 
enhance  release of 13C3 lactate into the medium (Figur  2(I-D)) and lower fractional enrichment in 
intracellular 13C3-pyruvate (3; Figure 2(I-B)). In contrast, there was no effect of selenite on 
13C3-pyruvate (Figure 2(II-B)) and th  stimulation of 13C3-lactate release was relatively lower from 
spher id cultures (Figure 2(II-D)) than from 2D cultur s (Figure 2(I-D)); indicating a lesser 
perturbation of selenite to glycolysis in sph oids than in 2D cells. Likewise, the selenite-induced 
changes in the Krebs cycle was also much less in spheroids than in 2D cells, as evidenced by the 
much reduced perturbation to the extent of 13C incorporation in  the Krebs cycle metabolites, 
cluding citrate and α-ketoglutarate (αKG) (Figure 2(II-E,II-F) versus Figure 2(I-E,I-F), respectively). 
In particular, the fractiona  enrichment of 13C4- ( ed boxes) and 13C3-citrate (green boxes) showed 
prominent differ nces between the two culture types (Figur  2(I-E,II-E)). As 13C4-citrate is a marker 
of pyruvate d hydrogenase (PDH)-ini iated Krebs cycl  activity [42] while 13C3-citrate results from 
pyruvate carboxylase (PCB)-initiated Krebs cycle reactions [34], these differences suggest a 
tial effect of selenite on both canonical a d anaplerot  Krebs cycle activities in A549 
spheroids ver us 2D cells. Other prominent differenc s in th  selenite eff ct on the two culture types 
involved Glu and GSH metabolism. The extent of nrichment n 13C2-Glu and -GSH (red boxes; 
Figur  2(I-I,I-J,II-I,I -J)) was much less attenua d in spheroids than in 2D cells. The 13C 
- l  tr i   i  i   ●, ●) indicates that these two 13C isotopologues can be 
etabolites , ,   f  
 
. . e i er ele ite esist e f     er i s Is t e t  ess e l ti  
 t e  ter rts 
 i i t  ti  t t  i  l it  i t  i  t   i   if t i  i  
 t  l   l ti  i  t i  i  t  t t f t  i   ll .   t i  
ti ,  f  ll l l it  t t t  f    ll      i  
lt  f  t t l  l i   I - .  f  t t t t l  i   i   i  t  
t t i   lt  f  t     ll  ( , i  ).  i   l ti  i  
 i    lt f l t  l it  t  f  t  i  f   ll  t t f   
ll  ( i  t , i  ).  l tt  t   l  f  l it  i  
l tili ti  [ ] i      ll .  l i   i  l  t t , t i  t t ,  
i  ( ft  l   t i  t ti ) f    ll ,  f  t t t   t t 
f ll  t   i   t i   l  f ti  f  t     lt . It i  i t ti  t  
t  t t   i  l ti l   i  t  l l  ( l   t i ) f ti  f  t   
lt  f  t     ll . It i  i l  t t  f ( ) f  i  t  f ti  
t i t  t  i  t i it  i  t   ll lt  [ ]. I   t , t    t i tf  
l ti i  t  l it  t    iff  i     ll t i it . 
. . l l sis  t e re s le es  ess t  ele ite i     er i s t  i  eir  
ell ter rts 
I  I  i t , .   l it  tt t  t t   i  l i l 
 i   ll   i   lt  ( i  ).    l  i t i  t  
i   i  t   l it  ( i  ). i i ,   l it  li it  t  
t ti  i  l   lif ti  i   ( i  ) t   ll lt  f  
( i  ), i  i  i t t it  t   f  i  l ti  f i t t ll  i  
i  t  i   ll lt ,  es i  . i t t it  t  t l   f  
t  ( i e ), t  it ti  i  (  i t   t   fl )     
 f   l it  t t e t i  t     .  t  i i iti   
i   i  i  (  i i t   t  I -  fl ) i  t    
 s i  ( i  ). 
 t i  iff   i   iff ti l t li   t  l it  
t   ll    lt . i    t  e t t f 13 6- l  (13 6- l ) 
t f i  t  l l i   t   l  t   i   lt    i  
i   t    f l it  t t t  t .     , ti l . i ifi t 
t ti  t  t  l l ti  ti it   i t i  el it -t t   ll    t  
 l  f 13 3 l t t  i t  t  i  ( i  (I- ))  l  f ti l i t i  
i t ll l  13 3- t  ( ; i  (I- )). I  t t, t    ff t f l it   
13 3- t  ( i  (II- ))  t  ti l ti  f 13 3-l t t  l   l ti l  l  f  
i  lt  ( i  (II- )) t  f   lt e  ( i  (I- )); i i ti   l  
t ti  f l it  t  l l i  i  i  t    l . i i , t  l it -i  
 i  t   l   l   l  i  i  t  i   ll ,  i   t  
  t ti  t  t  t t f 13  i ti  i  t   l  t lit , 
l i  it t   - t l t t  ( ) ( i  (II- ,II- )  i  (I- ,I- ), ti l ). 
I  ti l , t  f ti l i t f 13 4- (  )  13 3- it t  (  )  
i t iff  t  t  t  lt  t  ( i e (I- ,II- )).  13 4- it t  i    
f t   ( )-i i i t   le ti it  [ ] il  13 3- it t  lt  f  
t  l  ( )-i iti t   l  ti  [ ], t  iff  t  
ti l ff t f l it   t  i l  l t   l  ti iti  i   
i  s   ll . t  i t iff e  i  t e l it  ff t  t  t  lt  t  
i l  l    t li .  t t f i t  13 2- l   -  (  ; 
i e (I-I,I-J,II-I,I -J))   l  tt  i  i  t  i   ll .  13  
ato -resolved t acing shown in Figure 2 ( , ) i i t  t t t  t  13  i t l    nd ca es ha hese t o
13C isotopologues can be derived from the Krebs cycle reactions initiated by PDH-, PCB-, or both.
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This agrees with the differential selenite effect on canonical and anaplerotic Krebs cycle activities
described above.
Metabolites 2018, 8, x 5 of 16 
 
derived from t e Krebs cycle reactions initia ed by PDH-, PCB-, or both. This agrees with he 
iffe ential selenite effect on canonical and anaplerotic Krebs cycle activities described above. 
 
Figure 2. Glycolysis and the Krebs cycle respond less to selenite in A549 spheroids than in their 2D 
cell counterparts. A549 cells and spheroids were extracted for polar metabolites, which were 
quantified for the 13C isotopologues of various metabolites by IC-UHRFT-MS and for 13C3-lactate 
(Lac) by 1H-NMR, as described in the Materials and Methods. Oxidation of 13C6-Glc via glycolysis 
and Krebs cycle is traced along with the fractional distribution of relevant 13C labeled metabolites in 
control versus selenite-treated 2D cells (I) and spheroids (II), except for 13C3-lactate as µmoles/g 
protein. Not all possible isotopologues are shown. Numbers in X-axis are those of 13C atom in each 
isotopologue. →, ↔, and ---> indicate irreversible, reversible, and multi-step reactions, 
respectively; double dashed line depicts plasma or mitochondrial membrane; numbers in X-axis refer 
to those of 13C atoms in each isotopologue of metabolites. ●: 12C; ●, ●: respective 13C fate via the 1st 
turn of the pyruvate dehydrogenase (PDH)- or pyruvate carboxylase (PCB)-initiated Krebs cycle; 
ME: malic enzyme; αKG: αketoglutarate; GSH: glutathione; *: q (false discovery rate) ≤ 0.05; **: q ≤ 
0.01; ***: q ≤ 0.005; ****: q ≤ 5 × 10−6. n = 2 or 3. 
Similarly, selenite distinctly impacted glycolysis and the Krebs cycle activity in PANC1 2D cell 
culture (Figure 3I) versus spheroids (Figure 3II). At 10 µM, selenite significantly decreased 13C 
labeling in Krebs cycle metabolites and increased the amount of excreted 13C-lactate in the 2D cells 
but had little effect in the spheroids. The reduced enrichment by selenite in 13C2-Asp (red box, Figure 
3(I-K)) and 13C2-/13C4-citrate (red box, Figure 3(I-E); produced in the first and second Krebs cycle turn, 
respectively [42]) indicated disrupted PDH-initiated Krebs cycle activity while that in 13C3-Asp and 
13C3-citrate could result from perturbed PCB-initiated Krebs cycle reactions (green box, Figure 
3(I-K,I-E)). Again, the reduced enrichment of 13C2-Glu and -GSH (red box, Figure 3(I-I,I-J)) by selenite 
is consistent with attenuated PDH- and/or PCB-mediated Krebs cycle activities. However, these 
selenite-induced perturbations clearly observed in 2D cells (Figure 3(I-E,I-I–I-K)) were diminished in 
spheroids (Figure 3(II-E,II-I–II-K)). 
Glu 
1 
5 
Glu-GSH 
1 
5 
CO2 
Acetyl CoA 
1 
P
D
H
 
Krebs 
Cycle 
Asp 
J 
Malate 
Citrate 
Fumarate 
Succinate 
αKetoglutarate 
Isocitrate 
CO2 
CO2 
Oxaloacetate 
4 
Succinyl CoA 
1 
1 
4 
6 
1 
4 
1 
5 
13C6-Glc 
1 
6 
F6P 
P 
1 
6 
P 
1 
3 Pyruvate 
Lactate 
1 
3 
13C3-lactate 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 5 
F
ra
c
ti
o
n
 
Glu Ctl 
SeO3 
I 
Glycolysis 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 
F
ra
ct
io
n
 
Asp Ctl 
SeO3 
K 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 5 6 
F
ra
c
ti
o
n
 
F6P Ctl 
SeO3 
A 0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 
F
ra
ct
io
n
 
Lactate 
Ctl 
SeO3 
C 
0.0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0 1 2 3 
F
ra
ct
io
n
 
Pyruvate 
Ctl 
SeO3 
B 
D 
0 
30 
60 
90 
120 
150 
180 
Lac 
1
3
C
 m
m
o
le
/g
 p
ro
te
in
 
Media 
Ctl 
SeO3 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 
F
ra
c
ti
o
n
 
Fumarate 
Ctl 
SeO3 
G 
0.0 
0.2 
0.4 
0.6 
0.8 
0 1 2 3 4 
F
ra
ct
io
n
 
Malate 
Ctl 
SeO3 
H 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 5 
F
ra
c
ti
o
n
 
αKG 
Ctl 
SeO3 
F 
0.0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0 1 2 3 4 5 6 
F
ra
ct
io
n
 
Citrate Ctl 
SeO3 
E 
P
C
B
 
CO2 
1 
4 
II. 3D Spheroids 
Glu 
1 
5 
Glu-GSH 
1 
5 
Acetyl CoA 
1 
P
D
H
 
Krebs 
Cycle 
Asp 
Malate 
Citrate 
Fumarate 
Succinate 
αKetoglutarate 
Isocitrate 
CO2 
CO2 
Oxaloacetate 
4 
Succinyl CoA 
1 
1 
4 
6 
1 
4 
1 
5 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 5 
F
ra
c
ti
o
n
 
Glu Ctl 
SeO3 
I 
0.02 
0.00 
0.04 
1 
3 Pyruvate 
1 
6 
13C6-Glc 
Lactate 
1 
3 
13C3-lactate 
F6P 
P 
1 
6 
P 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 
F
ra
ct
io
n
 
Asp Ctl 
SeO3 
K 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 5 6 
F
ra
ct
io
n
 
F6P Ctl 
SeO3 
A 0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 
F
ra
c
ti
o
n
 
Lactate 
Ctl 
SeO3 
C 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 
F
ra
c
ti
o
n
 
Pyruvate 
Ctl 
SeO3 
B 
0 
100 
200 
300 
400 
1
3
C
 m
m
o
le
/g
 p
ro
te
in
 
Media Ctl 
SeO3 
D 
Glycolysis 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 
F
ra
ct
io
n
 
Malate Ctl 
SeO3 
H 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 5 
F
ra
c
ti
o
n
 
αKG Ctl 
SeO3 
F 
0.02 
0.00 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 
F
ra
ct
io
n
 
Fumarate 
Ctl 
SeO3 
G 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 5 6 
F
ra
ct
io
n
 
Citrate 
Ctl 
SeO3 
E 
P
C
B
 
CO2 
1 
4 
I. 2D Cells 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 5 
F
ra
c
ti
o
n
 
GSH Ctl 
SeO3 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1 2 3 4 5 
F
ra
ct
io
n
 
GSH Ctl 
SeO3 
J 
0.02 
0.00 
0.04 
D 
J 
* 
* 
** ** 
* 
* * 
* 
* 
*** 
** 
*** * 
i r . Glycolysis and the Krebs cycle respond less to selenite in A549 spheroids than in their
2D cell counterparts. A549 cells and spheroids were extracted for polar metabolites, hich ere
quantified for the 13 isotopologues of various etabolites by I - F - S and for 13 -lactate
(Lac) by 1 - R, as described in the aterials and ethods. xidation of 13 - lc via glycolysis
and rebs cycle is traced along with the fractional distribution of relevant 13C labeled metabolites
in control versus selenite-treated 2D cells (I) and spheroids (II), except for 13C -lactate as µ oles/g
protein. Not all possible isotopologues are shown. Nu bers in X-axis are those of 13C ato in each
isotopologue. →,↔, and —> indicate irreversible, reversible, and multi-step reactions, respectively;
double dashed line depicts plasma or mitochondrial membrane; numbers in X-axis refer to those
of 13C atoms in each isotopologue of metabolites.
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2.2. The Higher Selenite Resistance of 3D A549 and PANC1 Spheroids Is Not Due to Less Se Accumulation 
Than the 2D Counterparts 
One immediate question about the higher selenite resistance in the 3D spheroids was if this is 
due to less Se accumulation in their biomass than that of the corresponding 2D cells. To address this 
question, we performed parallel selenite treatments of A549 and PANC1 cells as 2D and 3D spheroid 
cultures for total Se analysis by ICP-MS. We found that total Se in 3D spheroids were higher than 
that in 2D cultures for both A549 and PANC1 cells (sum, Figure S1). The higher Se accumulation in 
3D biomass was a result of elevated selenite uptake from the media for A549 cells but not for PANC1 
cells (medium uptake, Figure S3). The latter suggests enhanced loss of absorbed selenite via 
volatilization [41] in 2D over 3D PANC1 cells. By analyzing Se in polar extracts, protein extracts, and 
residue (after polar and protein extractions) of A549 and PANC1 cells, we found that the Se content 
followed the order residue > protein > polar fractions for both 2D and 3D cultures. It is interesting to 
note that Se was enriched relatively more in the soluble (polar and protein) fractions of 2D than 3D 
cultures for both A549 and PANC1 cells. It is possible that some form(s) of Se in these fractions 
contribute to higher toxicity in the 2D cell cultures [40]. In any rate, there was no straightforward 
relationship between selenite uptake and observed differences in 2D and 3D cell toxicity. 
2.3. Glycolysis and the Krebs Cycle Respond Less to Selenite in A549 and PANC1 Spheroids than in Their 2D 
Cell Counterparts 
In SIRM experiments, 6.25 µM selenite attenuated net growth and induced morphological 
changes in A549 cells grown in 2D cultures (Figure S2A). Such changes were less evident in the 
corresponding 3D spheroids at 10 µM selenite (Figure S2B). Likewise, 10 µM selenite elicited greater 
perturbations in morphology and proliferation in 2D (Figure S3A) than 3D cell cultures of PANC1 
(Figure S3B), which is consistent with the presence of a higher population of resistant cells in 
spheroid than in 2D cell cultures, as described above. Consistent with the PrestoBlue assay for 
growth (Figure 1A), the mitotic index (as indicated by the PCNA fluorescence) was reduced by 3 
days of 100 µM selenite treatment in both A549 and PANC1 spheroids. The growth inhibition was 
accompanied by increased necrosis (as indicated by the RIP-1 fluorescence) in both A549 and 
PANC1 spheroids (Figure S2). 
These phenotypic ifferences were accompanied by differential metabolic responses to selenite 
between 2D cell and 3D spheroid cultures. Figure 2 compares the extent of 13C6-glucose (13C6-Glc) 
transformation through glycolysis and the Krebs cycle between A549 in 2D culture and as spheroids 
in resp nse to 24 h of selenite treatm nts at 6.25 µM and 10 µM, respectively. Significant 
perturbations to the glycolytic activity were evident in selenite-treated 2D cells based on the 
enhanced release of 13C3-lactate into the medium (Figure 2(I-D)) and lower fractional enrichment in 
intrac llular 13C3-pyruvate (3; Figure 2(I-B)). In contrast, there was no effect of selenite on 
13C3-pyruvate (Figure 2(II-B)) and the stimulation of 13C3-lactate release was relatively lower from 
spheroid c ltures (Figure 2(II-D)) than fro  2D cultures (Figure 2(I-D)); indicating a lesser 
pert rb tion of selenite to glycolysis in sph roids tha  in 2D cells. Likewise, the selenite-induced 
changes in the Krebs cycle was also much less in spheroids than in 2D cells, as evidenced by the 
much reduced perturbation to the extent of 13C incorporation into the Krebs cycle metabolites, 
including citrate and α-ketoglutarate (αKG) (Figure 2(II-E,II-F) versus Figure 2(I-E,I-F), respectively). 
In particular, the fractional enrichment of 13C4- (red boxes) and 13C3-citrate (green boxes) showed 
prominent differences between the two culture types (Figure 2(I-E,II-E)). As 13C4-citrate is a marker 
of pyruvate dehydrogenase (PDH)-initiated Krebs cycle activity [42] while 13C3-citrate results from 
pyruvate carboxylase (PCB)-initiated Krebs cycle reactions [34], these differences suggest a 
differential effect of selenite on both canonical and anaplerotic Krebs cycle activities in A549 
spheroids versus 2D cells. Other prominent differ nces in the selenite effect on t e two culture types 
involved Glu and GSH metabol sm. The extent of enrichm nt in 13C2-Glu and -GSH (red boxes; 
Figure 2(I-I,I-J,II-I,II-J)) was much ess atte uated in spheroid than in 2D cells. The 13C 
atom-resolved tracing shown in Figure 2 (●, ●) indicates th  these two 13C isotopologues can be 
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fol o ed the order residue > protein > polar fractions for both 2  and 3  cultures. It is interesting to 
note that Se as enriched relatively ore in the soluble (polar and protein) fractions of 2  than 3  
cultures for both 549 and P 1 cel s. It is possible that so e for (s) of Se in these fractions 
contribute to higher toxicity in the 2  cel  cultures [40]. In any rate, there as no straightfor ard 
relationship bet een selenite uptake and observed differences in 2  and 3  cel  toxicity. 
2.3. lycolysis and the rebs ycle espond Less to Selenite in 549 and P 1 Spheroids than in Their 2  
el  ounterparts 
In SI  experi ents, 6.25  selenite attenuated net gro th and induced orphological 
changes in 549 cel s gro n in 2  cultures (Figure S2 ). Such changes ere less evident in the 
corresponding 3  spheroids at 10  selenite (Figure S2B). Like ise, 10  selenite elicited greater 
perturbations in orphology and proliferation in 2  (Figure S3 ) than 3  cel  cultures of P 1 
(Figure S3B), hich is consistent ith the presence of a higher population of resistant cel s in 
spheroid than in 2  cel  cultures, as described above. onsistent ith the PrestoBlue assay for 
gro th (Figure 1 ), the itotic index (as indicated by the P  fluorescence) as reduced by 3 
days of 100  selenite treat ent in both 549 and P 1 spheroids. The gro th inhibition as 
acco panied by increased necrosis (as indicated by the IP-1 fluorescence) in both 549 and 
P 1 spheroids (Figure S2). 
These phenotypic d fferenc s ere acco panied by differential etabolic responses to selenite 
bet een 2  cel  and 3  spheroid cultures. Figure 2 co pares the extent of 13 6-glucose (13 6- lc) 
transfor ation through glycolysis and the rebs cycle bet een 549 in 2  culture and as spheroids 
in response to 24 h of sele ite treat ents at 6.25  and 10 , respectively. Significant 
perturbations to the glycolytic activity ere evident in selenite-treated 2  cel s based on the 
enhanced release of 13 3-lactate into the ediu  (Figure 2(I- )) and lo er fractional enrich ent in 
intracel ular 13 3-pyruvate (3; Figure 2(I-B)). In contrast, there as no effect of selenite on 
13 3-pyruvate (Figure 2(II-B)) and the sti ulation of 13 3-lactate release as relatively lo er fro  
spheroid c ltures (Figure 2(II- )) than from 2  cultures (Figure 2(I- )); indicating a lesser 
perturb tion f selenite to glycolysis in spheroids han in 2  cel s. Like ise, the selenite-induced 
changes in the rebs cycle as also uch less in spheroids than in 2  cel s, as evidenced by the 
uch reduced perturbation to the extent of 13  incorporation into the rebs cycle etabolites, 
including citrate and α-ketoglutarate (α ) (Figure 2(II-E,II-F) versus Figure 2(I-E,I-F), respectively). 
In particular, the fractional enrich ent of 13 4- (red boxes) and 13 3-citrate (green boxes) sho ed 
pro inent differences bet een the t o culture types (Figure 2(I-E,II-E)). s 13 4-citrate is a arker 
of pyruvate dehydrogenase (P )-initiated rebs cycle activity [42] hile 13 3-citrate results fro  
pyruvate carboxylase (P B)-initiated rebs cycle reactions [34], these differences suggest a 
differential effect of selenite on both canonical and anaplerotic rebs cycle activities in 549 
spheroids versus 2  c l s. ther pro inent differences in t e selenite effect on t e t o culture types 
involved lu and S  etabolis . The extent of enrich ent in 13 2- lu and - S  (red boxes; 
Figure 2(I-I,I-J,II-I,II-J)) as uch less atte u t d in sphero ds than in 2  cel s. The 13  
ato -resolved tracing sho n in Figure 2 ( , ●) indicat s that these t o 13  isotopologues can be : respe tive 13C fa e via he 1st turn
of the pyruvate dehydrogenase (PDH)- or pyruvate carboxylase (PCB)- nitiated Krebs ycle; ME:
malic enzyme; αKG: αketoglut rate; GSH: glu athione; *: q (false discovery rate) ≤ .05; **: q ≤ 0.01;
**: q ≤ 0.005; ***: q ≤ 5 × 10−6. n = 2 or 3.
i il rl selenite distinctly impacted glycoly is and the Krebs cycle ac iv ty in PANC1 2D
e l culture (Figure 3I) ver us spheroids (Figure 3II). At 10 µM, sel nite significantly decreased
13C labeling in Krebs cycle me abolites and increased the amount of excreted 13C-lactate in the
2D cells but had l ttle ffect in the spheroids. The reduced enrichme t by selenit in 13C2-Asp
(red box, Figure 3(I-K)) and 13C2-/13C4-citrate (red box, F gure 3(I-E); produced in the first and
s cond Krebs cycle turn, respectiv ly [42]) i dicated disrupted PDH-initiated Krebs cycle activity
while that in 13C3-Asp and 13C3-citrate could result from perturbed PCB-initiat d Krebs cycl
reactions (gree box, Figure 3(I-K,I-E)). Again, the reduced enrichment of 13C2-Glu and -GSH
(red box, Figure 3(I-I,I-J)) by selenite is consistent with attenuated PDH- and/or PCB-mediated
Kr bs cycle activities. However, these selenite-i duced perturbations clearly observed in 2D cells
(Figure 3(I-E,I,J,K)) were diminished in spheroids (Figure 3(II-E,I,J,K)).
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Figure 3. Glycolysis and the Krebs cycle respond less to selenite in PANC1 spheroids than in their 2D
cell counterparts. Extraction of polar metabolites and their analysis are as described in Figure 2, so are
all symbols and abbreviations. (I) Metabolite responses in 2D cultures; (II) metabolite responses in
3D cultures.
We also noted two clear metabolic differences in PANC1 2D cell and spheroids, regardless
of the selenite treatment. One was the higher enrichment in 13C3-fructose-6-phosphate (F6P) in
spheroids (Figure 3(II-A)) than in 2D cells (Figure 3(I-A)). F6P can be produced from 13C3-pyruvate
via gluconeogenesis [35]. The other was the higher enrichment in the 13C1-isotopologues of fumarate,
malate, and Asp in spheroids (Figure 3(II-G,II-H,II-K)) than in 2D cells (Figure 3(I-G,I-H,I-K)). These
isotopologues (tracked by
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in Figure S4A) can be produced via the reve sible reactions of malic enzyme
(ME). Alternatively, thes 13C1-i otopologues can b formed by the condensation of 13C2-1,2-OAA
with unlabeled acetyl CoA and subsequent Krebs cycle reactions, as depicted in Figure S4B (
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Figure 2. Glycolysis and the Krebs cycle respond less to selenite in A549 spheroids than in their 2D 
cell counterparts. 549 cells and spheroids were extracted for polar metabolites, which were 
quantified for the 13C isotopologues of various metabolites by IC-UHRFT-MS and for 13C3-lactate 
(Lac) by 1H-NMR, as described in the Materials and Methods. Oxidation of 13C6-Glc via glycolysis 
and Krebs cycle is traced along with the fractional distribution of relevant 13C labeled metabolites in 
control versus selenite-treated 2D cells (I) and spheroids (II), except for 13C3-lactate as µmoles/g 
protein. Not all possible isotopologues are shown. Numbers in X-axis are those of 13C atom in each 
isotopologue. →, ↔, and ---> indic te irreversible, reversible, and multi-step reactions, 
respective y; double dashed line d picts plasma or mitochondrial membrane; numbers in X-axis refer 
to those of 13C atoms in each isotopol gue of metabolites. ●: 12C; ●, ●: respective 13C fate via the 1st 
turn of the pyruv te dehydrogenase (PDH)- or pyruvate carboxylase (PCB)-initiated Krebs cycle; 
ME: malic enzyme; αKG: αketoglutar te; GSH: glutathione; *: q (false discovery rate) ≤ 0.05; **: q ≤ 
0.01; ***: q ≤ 0.005; ****: q ≤ 5 × 10−6. n = 2 or 3. 
Similarly, selenite distinctly impacted glycolysis and the Krebs cycle activity in PANC1 2D cell 
culture (Figure 3I) versus spheroids (Figure 3II). At 10 µM, selenite significantly decreased 13C 
labeling in Krebs cycle metabolites and increased the amount of excreted 13C-lactate in the 2D cells 
but had little effect in the spheroids. The reduced enrichment by selenite in 13C2-Asp (red box, Figure 
3(I-K)) and 13C2-/13C4-citrate (red box, Figure 3(I-E); produced in the first and second Krebs cycle turn, 
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). If the
latter is the case, one would expect the fracti nal nrichment of 13C1-fumarate to be higher than that of
13C1-m late, which was no the case. We hypothesiz that ME-mediat d eactions contribut d at least
i part to the production of 13C1-is topol gues of the Krebs cycle intermediates in PANC1 spheroids.
Thu , spheroid formation led to a higher resistance to selenite toxicity in A549 or PANC1 cells,
which was reflected espectiv ly in the r attenuated or lack of changes in glycolysis, the Krebs cycle,
and GSH metabolism in response to selenite. Additional metabolic rewiring occurred in PANC1
spheroids compared with 2D cultures, most likely nvo ving enhanc d gluconeogenes s and malic
enzyme activity.
2.4. Pyrimidine and the Hexosamine Biosyn hetic Pathways Respon Less to Selenite A549 And PANC1
Spheroids Than in Their 2D Cell Counterparts
As Asp is the direct precursor to pyrimidine ring synthesis, which is required for cell
proliferation, we then asked if distinct selenite-induced changes of Asp synthesis results in differential
inhibition of pyrimidine ring synthesis in 2D versus spheroid cultures of A549 and PANC1
cells. Figure 4 shows the 13C enrichment patterns of various precursors and products of uridine
synthesis in A549 cells and spheroids including those of the pyrimidine ring and the ribosyl unit,
i.e., ribulose/ribose-5-phosphate (R5P) of the pentose phosphate pathway (PPP) and phosphoribosyl
pyrophosphate (PRPP). Also tracked were the 13C enrichment patterns of the intermediates of the
hexosamine biosynthetic pathway (HBP), leading to the synthesis of UDP-N-acetylglucosamine
(UDPGlcNAc).
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It is clear that the differential 13C enrichment patterns of 13C2- s i sele ite-treate 2 549
cells vers s spheroi s ere aintai e in the inter e iates of the uracil ring synthesis such as
-carba oylaspartate (NCAsp) and orotate (Figure 4(I-B,I-C) versus Figure 4(II-B,II-C), respectively).
Subsequent conversion of these 13C-labeled precursors into the uracil ring of UTP was also differentially
inhibited by selenite in 2D cells (Ring, Figure 4(I-F)) versus spheroids (Ring, Figure 4(II-F)).
In contrast, selenite had a negligible effect on the extent of 13C incorporation into R5P and PRPP
in both 2D cells (Figure 4(I-D,I-E)) and spheroids (Figure 4(II-D,II-E)). However, differential inhibition
in the incorporation of the 13C5-ribosyl unit of PRPP into UTP by selenite was evident for 2D A549 cells
(cf. 5, Figure 4(I-F)) versus spheroids (cf. 5, Figure 4(II-F)). These results suggested that the differential
blockade of uracil nucleotide synthesis by selenite is most likely to be mediated via the inhibition of
Asp production by the Krebs cycle and of ribosyl incorporation by reactions downstream from PRPP
production, e.g., orotate hosphoribosyltransferase.
Furthermore, distinct 13C enrichment patterns of the HBP intermediates, N-acetylglucosamine-
6-phosphate (NAcGN6P, Figure 4(I-G) versus Figure 4(II-G)) and N-acetylglucosamine-1-phosphate
( AcGN1P, Figure 4(I-H) versus Figure 4(II-H)) between selenite-treated 2D cells and spheroids of A549
were evident, particularly for the 13C6- and 13C8-isotopologues (respectively 6 and 8, Figure 4(I-G,I-H)
versus Figure 4(II-G,II-H)). It is interesting to note the opposite effect of selenite on the enrichment
patterns of the 13C6- versus 13C8-NAcGN6P for both 2D cells and spheroids. Since the synthesis of
13C8- from 13C6-NAcGN6P presumably requires 13C2-acetyl CoA, the large reduction in the extent
of 13C8-NAcGN6P enrichment may reflect reduced synthesis of 13C2-acetyl CoA via PDH and/or
ATP-citrate lyase (ACLY) activity (cf. Figure 2 and Figure S4A; [43]) and/or inhibition in the acetylation
of glucosamine-6-phosphate. The former is consistent with the inhibition of the Krebs cycle by selenite
described above (cf. Figure 2). The increased fractional enrichment of 13C6-NAcGN6P was reflected in
that of the 13C6-UDPGlcNAc product for both 2D cells (Figure 4(I-I)) and spheroids (Figure 4(II-I)).
This increase could also have contribution from decreased synthesis and/or incorporation of the 13C
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labeled UTP precursor into UDPGlcNAc, as evidenced from the large reduction in the enrichment
of 13C11-15-UDPGlcNAc for both 2D cells and spheroids (11–15, Figure 4(I-I,II-I)). The production of
these isotopologues requires 13C-labeled UTP (Figure 4) [43]. Further noted was the lower fractional
enrichment in these isotopologues in spheroids compared with 2D cells under control conditions,
which corresponded to the 13C enrichment patterns of the precursors of UTP (Figure 4(I-A–I-F) versus
Figure 4(II-A–II-F)) and HBP intermediates (Figure 4(I-G–I-I),versus Figure 4(II-G–II-I)). These results
suggest a lower capacity for UTP synthesis (both in terms of the 13C5-ribosyl incorporation and
13C-ring synthesis) and HBP (cf. also higher enrichment of the all 12C or 0 isotopologue) in spheroids
than in the 2D counterpart.
Similar to A549 cells, we observed differential selenite inhibition of HBP activity and UTP
synthesis, but not of PPP activity and PRPP production in PANC1 2D cell culture (Figure 5I versus
spheroids (Figure 5II. Likewise, UDPGlcNAc synthesis was differentially inhibited by selenite in the
two PANC1 systems (Figure 5(I-I) versus Figure 5(II-I)). Moreover, intrinsically lower capacity for
UTP synthesis and HBP was evident in PANC1 spheroids than 2D cells (cf. higher enrichment of 0 in
Figure 5II versus Figure 5I).
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Figure 5. Pyrimidine and the hexosamine biosynthetic pathways respond less to selenite in PANC1
spheroids than in their 2D cell counterparts. The same polar extracts from Figure 3 were analyzed
by IC-UHR FT-MS. All symbols and abbreviations are as in Figure 4. (I) Metabolite responses in 2D
cultures; (II) metabolite responses in 3D cultures
3. Discussion
Selenite has been investigated extensively for anti-cancer properties in 2D cultures of different
cancer cells types including A549 cells [40,44–51]. But virtually nothing is known about its effect on 3D
spheroids, which exhibit cell–cell and cell–matrix interactions absent from the 2D cultures. To the best
of our knowledge, little is known about the effects of selenite on PANC1 cells either as 2D or spheroid
cultures. We showed here that selenite has a complex effect on the spheroid cultures of both A549 and
PANC1 cells including responses from a mixed population of resistant and sensitive cells (Figure 1).
Although difficult to quantify, it is clear that spheroids were more resistant to selenite than 2D cells
when comparing their 1-day IC50 values, respectively >100 µM versus 6.25 µM for A549 and >150 µM
versus 10 µM for PANC1 (cf. Figure 1, Figures S2 and S3). This resistance of 3D spheroids to selenite
toxicity did not result from less Se accumulation into cell biomass (Figure S1). A higher resistance to
selenite toxicity with comparable growth rates was also evident for A549 spheroids formed without
the magnetic NS (data not shown). These illustrated the influence of the microenvironment, albeit
in a simple form, on cancer cells’ response to toxicants. In addition, the selenite toxicity for the
sensitive population of PANC1 spheroids with 1-day treatment appeared to be higher than that of
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A549 spheroids (Figure 1). However, after 2 and 3 days of treatment, the opposite was evident for
the selenite toxicity in PANC1 and A549 spheroids (Table 1). Nevertheless, selenite was toxic to both
sensitive and resistant populations of A549 and PANC1 spheroids after prolonged exposure.
13C6-Glc-based SIRM investigations on 1-day selenite treatment of A549 and PANC1 cells and
spheroids corroborated with the 1-day IC50 trend. Both A549 and PANC1 spheroids displayed less
selenite-induced perturbations in the activities of the central metabolic pathways, including glycolysis,
the Krebs cycle (Figures 2 and 3), HBP, and pyrimidine ring synthesis (Figures 4 and 5), relative to
the 2D cell counterparts. These growth-related metabolic effects are unlikely to be attributed to the
presence of NS since NS had a negligible effect on spheroid growth rates and selenite-induced growth
attenuation, as indicated above. In addition, the relatively lesser inhibition of these pathways in PANC1
than A549 spheroids was consistent with the lower growth attenuation of the former. Together, these
results are consistent with the requirement of these pathways for cell growth. It should also be noted
that these metabolic changes occurred before appreciable growth inhibition was evident for A549
spheroids (cf. Figure 1 versus Figure 2), making them more sensitive indicators of selenite toxicity.
Moreover, it is likely that the metabolic perturbations manifested in both 3D spheroids resulted from
the response of the sensitive populations.
The disruption of GSH synthesis by selenite in 2D A549 cells (Figure 2(I-J)) presumably
compromises anti-oxidative defense, which can be related to the enhanced production of reactive
oxygen species (ROS) and ROS-mediated cell death observed by Park et al. [49] in selenite-treated
A549 cells. This could be the case for the sensitive populations in both A549 and PANC1 spheroids, as
evident from the burst of ROS production in 1 day of 10–20 µM selenite treatment (Figure 1C). As such,
the relatively less attenuated GSH synthesis in A549 and PANC1 spheroids than in 2D cultures could
lead to less oxidative damages and better survival for the resistant populations, which could in turn
contribute to the higher IC50 for selenite in A549 and PANC1 spheroids than those in the 2D cell
counterparts. However, the much lower ROS production in A549 than PANC1 spheroids elicited
by the 3-day treatment of selenite suggests that excess ROS was not the key to cell death in A549
spheroids (cf. Figure S2C). Two alternative possibilities warrant further investigation in terms of
selenite’s toxic mechanism in A549 spheroids, e.g., (1) inhibition of glutaminolysis via enhanced GLS1
degradation [52]; (2) altered detoxification mechanism involving direct interaction of selenite with
GSH to form selenodiglutathione (GSSeG) [53] and subsequent efflux of GSSeG from cancer cells [54].
Besides differential metabolic responses to selenite for spheroids versus 2D cells, we also noted
their intrinsically distinct metabolic activities, i.e., reduced capacity for lactate release, UTP synthesis
and HBP in both A549 and PANC1 spheroids (Figures 4 and 5), and activation of gluconeogenesis
in PANC1 spheroids (Figure 3). Attenuated lactate release by A549 spheroids (Figure 2(II-D)) versus
Figure 2(I-D)) could be related to the differences in growth rates (2.9 days for spheroids versus 1.2 days
for 2D cells in doubling time). But, this is unlikely to be the case for PANC1 spheroids (Figure 3(II-D))
versus Figure 3(I-D)) since their doubling time (0.6 days) was shorter than 2D cells (1.8 days). Reduced
UTP synthesis presumably led to a lower capacity for UDPGlcNAc synthesis in spheroids than 2D
cells. UDPGlcNAc is required for O-linked N-acetylglucosamine modification (O-GlcNAcylation)
of regulator proteins, including those important for cancer development and survival [55–59]. It is
possible that this difference in capacity for O-GlcNAcylation of proteins between spheroids and 2D
cells is involved in modulating their differential responses to selenite toxicity. Further investigations
will be required to test this hypothesis. It is also foreseeable that enhanced capacity for gluconeogenesis
in PANC1 spheroids could improve their survival in a hostile hypoxic tumor microenvironment, where
glucose is depleted due to its increased glycolytic conversion to lactate and extracellular release of
lactate [60]; the latter response was observed for selenite treatment in the more sensitive A549 spheroids
(Figure 2(II-D) versus Figure 3(II-D)). Again, we plan to investigate this hypothesis in future studies.
In summary, both NSCLC and PDAC cancer cell spheroids displayed much higher resistance to
anti-cancer selenite toxicity than their 2D cell counterparts in terms of cell growth, which was associated
with attenuated response of growth- and survival-requiring central metabolic activities. This resistance
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can be attributed, at least in part, to the presence of a resistant cell population, presumably as a result of
cell–cell and cell–matrix interactions in the spheroids. These interactions also led to reduced intrinsic
capacity of UDPGlcNAc synthesis in A549 and PANC1 spheroids and activation of gluconeogenesis in
PANC1 spheroids, which could be involved in modulating cancer spheroid metabolism and survival.
4. Materials and Methods
4.1. IC50 Determination for Selenite Treatment of 2D PANC1 Cells
IC50 for sodium selenite (Na2SeO3; Sigma S-1382) in PANC1 cells were initially determined in
96-well plates and further determined in 6-well plates. For 6-well plate (Greiner Bio-one CELLSTAR®
657160), PANC1 cells were grown in DMEM (Sigma D5030; supplemented with sodium bicarbonate
3.7 g/L (pH 7.2), 2 g/L glucose, 2 mM L-glutamine, 10% FBS, 100 U/mL penicillin and 100 µg/mL
streptomycin) for two days (reaching 60~70% confluency) before titrating with 0, 2, 10, 20, 50, 200 µM
sodium selenite for 26 h. At the end of the treatment, cell viability was determined by neutral red assay.
In brief, cell media were aspirated and cells were incubated in 2 mL neutral red solution (33 µg/mL in
DMEM) at 37 ◦C and 5% CO2 for 3 h. At the end of the incubation, neutral red solution was aspirated
and cells were washed with 2 mL PBS twice. After removing PBS, cells were lysed in 1 mL lysis
buffer containing 50% ethanol and 1% acetic acid in water. Lysates were transferred to a 96-well plate
(125 µL/well, in triplicates) and A540 was measured in a plate reader. Dose response curves were
plotted using A540 with background subtraction and normalization to control cells. IC50 was deduced
from curve fitting using SigmaPlot.
4.2. Spheroid Formation, Culturing, and Growth Assay
A549 or PANC1 cells were grown in 6-well plates to 50–70% confluence in DMEM growth medium
at 37 ◦C/5% CO2 before treating cells with NanoShuttlesTM-PL (NS, n3D, Biosciences, Inc., Houston,
TX, USA) at 1 µL/104 cells overnight according to the vendor’s protocol. NS-loaded cells were then
trypsinized, counted, and seeded in a cell-repellent round-bottom 384-well plate at 1000 cells per well.
We have separately determined this cell seeding density to be within the linear range of spheroid
growth as a function of cell seeding density. The plate was held below a 384-well spheroid drive
(n3D) initially for 15 min in the biosafety hood and followed by 45 min at 37 ◦C/5% CO2 for spheroid
formation. The drive was then removed and spheroids were allowed to grow for 3 days before medium
change to DMEM containing 0 to 500 µM selenite. Spheroid growth was assayed daily using the
PrestoBlue® live cell fluorescent stain reagent (Thermofisher, Waltham, MA, USA) [61], which enables
in situ monitoring of cellular reducing activity. PrestoBlue® reduction was followed for 30 min at
3–5 min intervals for each well in the 384-well plate using a Cytation 3 imaging microplate reader
(BioTek, Winooski, VT, USA) set at 37 ◦C with 5% CO2. The slope of the fluorescence versus time was
used to plot the selenite dose-response curve (cf. Figure 1A), from which IC50 for the selenite treatment
was estimated. IC50 values were determined by non-linear regression analysis using Kaleidagraph
(Synergy Software, version 4.5) as the Hill equation or the Hill equation modified to two components
(sensitive and resistant).
y = ymin + D/[1 + (c/IC50)n]
where D is the change in the number of cells, ymin is the plateau value at high concentrations, c, of the
inhibitor and n is the Hill coefficient. For biphasic curves, this equation was modified as follows:
y = ymin + D/[1 + (c/IC50)n] − a.c
where a represents the slope of the “resistant” cell population.
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4.3. 13C SIRM Experiments for 2D Cells and Spheroids
2D cell experiments were performed in 10-cm plates with cells grown to 50–70% confluence in
DMEM growth medium.
PANC1 (passage 11, 5 × 105) cells were seeded on 10-cm plates and cultured in DMEM
growth medium using dialyzed, exosome-depleted FBS. Exosome-depleted FBS was prepared by
ultracentrifugation at 120,000× g for 2 h followed by filtration through a sterile 0.22 µm vacuum
filter. Four days after seeding, media were replaced with fresh media containing either 0.2% 12C6-Glc
(unlabeled) or 13C6-Glc, without or with 10 µM SeO3 in triplicates. Aliquots of 200 µL media were
collected at 0, 12 and 24 h after treatment started and spun at 3500× g for 15 min at 4 ◦C to remove
debris. Aliquots of 100 µL supernatants were subject to protein precipitation by mixing with 400 µL
cold acetone, incubating at −80 ◦C for 30 min before centrifugation at 14,000× g for 10 min at 4 ◦C.
Supernatants were aliquoted and lyophilized for NMR analysis. Such acetone extraction method
efficiently precipitated proteins and recovered polar metabolites from the media, similarly as the
10% trichloroacetic acid method [40] but without adding salts (Fan, unpublished data). At the end
of 24 h treatment, cells were washed in cold PBS, metabolism quenched in cold acetonitrile, and
polar/non-polar metabolites extracted in acetonitrile:water:chloroform (2:1.5:1 v/v/v) as described
previously [62]. Polar extracts were aliquoted and lyophilized for NMR and IC-UHR FT-MS analyses.
The protein pellets were washed in methanol, dried in Vacufuge (Eppendorf, Hamburg, Germany), and
re-dissolved in SDS buffer containing 62.5 mM Tris (pH 6.8), 2% SDS and 1 mM DTT using mini-pestles.
Protein concentrations were measured by microBCA assay (Pierce Chemical, Dallas, TX, USA), per
vendor’s protocol. Of note, the metabolic response of PANC1 cells to selenite did not depend on
passage numbers or different time of the experiments. This was also the case for A549 cells provided
that the passage numbers do not go beyond 30.
To prepare spheroid cultures for SIRM experiments, 464 µL of NanoShuttlesTM was added for
16–18 h to the cells grown in a 10-cm plate at 70% confluency. Then, cells were washed twice with
IX PBS, detached from the plate using trypsin, and counted using a hemocytometer. The trypsinized
cells were resuspended in DMEM growth medium before seeding in 6-well plates at a density of
400,000 cells/well. A 6-well magnetic levitation drive was put on top of the 6-well plate containing
cells for 15 min in the biosafety hood. The cells were then transferred to a 37 ◦C/5% CO2 incubator
and incubated for a further 45 min before removing the magnetic drive. Cells were then monitored
daily and growth media was renewed every two days. After four days of growth, cells were treated
with 10 µM selenite and 13C6-Glc for 24 h. Media at 50 µL aliquots were collected at 0 and 24 h after
selenite/13C6-Glc treatment. At the end of incubation, spheroids were held with the 6-well magnetic
holder during medium removal and washed twice with IX ice cold PBS and once with nanopure water,
followed by quenching and extraction of polar metabolites twice each with 1.0 mL 70% methanol/well.
This simultaneous quenching/extraction method is compatible with immunofluorescence analysis and
gave reproducible and comparable metabolite profiles as the acetonitrile-based quenching/extraction
method described above for 2D cell cultures (Fan et al., unpublished data). The method efficiently
quenches the hydrolysis of high-energy metabolites as evidenced by the high energy charge ratios
calculated for A549 (ca. 0.9) and PANC1 (0.98) spheroids. The polar extracts were lyophilized overnight
and subjected to IC-UHR FT-MS analysis. The cell residues were extracted and analyzed for proteins as
described above. Polar metabolites from the media were extracted in 80% acetone as described above.
4.4. IC-UHR FT-MS Analysis
Ion chromatography-ultra high-resolution Fourier transform-MS (IC-UHR FT-MS) was performed
as previously described [33]. Briefly, polar extracts were reconstituted in 20 µL nanopure water, and
analyzed by a Dionex ICS-5000+ ion chromatograph interfaced to an Orbitrap Fusion Tribrid mass
spectrometer (Thermo Fisher Scientific, San Jose, CA, USA) operating at a resolution setting of 500,000
(FWHM at m/z 200) on MS1 acquisition to capture all 13C isotopologues. The chromatograph was
outfitted with a Dionex IonPac AG11-HC-4 µm RFIC&HPIC (2 × 50 mm) guard column upstream
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of a Dionex IonPac AS11-HC-4 µm RFIC&HPIC (2 × 250 mm) column. Chromatography and mass
spectrometric settings were the same as described previously [30] with an acquisition m/z range of
80 to 700. Metabolites and their isotopologues were identified by chromatographic retention times and
their m/z values compared with those of the standards. Peak were integrated and the areas exported
to Excel via the TraceFinder 3.3 (Thermo, Waltham, MA, USA) software package. Peak areas were
corrected for natural abundance as previously described [63], after which fractional enrichment and
µmoles metabolites/g protein were calculated to quantify 13C incorporation into various metabolites.
4.5. 1H-NMR Analysis of Medium Extracts
Lyophilized medium extracts were redissolved in 35 µL D2O containing 8.81 nmoles of d6-DSS
(2,2-Dimethyl-2-silapentane-5-sulfonate, Cambridge Isotope Laboratories, Tewksbury, MA, USA) for
1D 1H-NMR analysis using a 1.7 mm inverse triple-resonance HCN cryoprobe on a Bruker AVANCE
III NMR at 16.45 T (Bruker Corp., Billerica, MA, USA). A 1H 90◦ pulse with solvent presaturation was
used to acquire 1D 1H spectra with a 8403 Hz spectral width, 2 s acquisition time, 4 s relaxation delay,
and 512 transients. The free induction decays were Fourier-transformed with 1 Hz line-broadening
and zero-filled to 131,072 points. The “peak picking” routine in the MestReNova software (Mestrelab
Research S.L., Santiago de Compostela, Spain) was used to quantify the 13C satellites of the methyl
resonance of lactate, which represented 13C3-lactate based on the splitting patterns. The lactate peak
areas were calibrated for nmoles against that of the methyl resonance of d6-DSS and normalized to the
cell protein content. The final 13C3-lactate content in the media was expressed as mmole/g protein.
4.6. Immunofluorescence Measurements
3D Spheroids were suspended in HistoGel (Thermo Scientific HG-4000-012). After solidification,
HistoGel pellets were fixed in 10% neutral buffered formalin for 24 h, followed by paraffin embedding,
sectioning at 4 µm thickness, and slide mounting. The slides were deparaffinized, rehydrated, subjected
to heat-induced epitope retrieval (hier) by microwaving in sodium citrate buffer (10 mM sodium citrate,
0.05% tween 20, pH 6.0) for 10 min at a sub-boiling temperature. For immunofluorescence analysis,
slides were treated with AlexaFluor™ Tyramide Superboost™ kits (Invitrogen, Carlsbad, CA, USA) as
per manufacturer’s instructions, followed by primary and secondary antibody treatments as described
previously [33]. The following primary antibodies were used: PCNA (PC10) mouse mAb (1:4000, Cell
Signaling, Danvers, MA, USA, #2586) and RIP (D94C12) XP® rabbit mAb (1:100, Cell Signaling #3493).
Slides were mounted in Prolong™ Gold Antifade Mountant with DAPI (Thermo Fisher Scientific
P36935) before imaging. Images were acquired at 40×magnification using a laser scanning confocal
microscope Olympus Fluoview™ FV1200.
4.7. Se Analysis by Inductively-Coupled Plasma-Mass Spectrometry (ICP-MS)
2D and 3D cells were cultured in 6-well plates, as described in 4.2 and 4.3. A549 cells (passage 15)
were treated with 6.25 µM (2D) or 10 µM selenite (3D) for 24 h with 200 µL media sampled at 0 and 24 h
after selenite treatment. Both 2D and 3D PANC1 (passage 20) cells were treated with 10 µM selenite for
24 h and media sampled as described above. Then 10 µL aliquots of media were digested in triplicate
in 0.5 mL concentrated nitric acid (Aristar Plus, VWR chemicals) at 150 ◦C for 10 min with maximal
pressure of 200 psi and power of 150 W using Discover SP microwave digestor (CEM, Matthews, NC,
USA). At the end of 24 h treatment, cells were washed in cold PBS, quenched in cold 70% methanol,
and extracted for polar metabolites as described above. The protein pellets were then extracted using
SDS/Tris buffer and protein concentrations were measured by microBCA assay as above. Both polar
and protein extracts were aliquoted in duplicates and lyophilized. The residue pellets were dried
in a Vacufuge (Eppendorf) and pre-digested in 100 µL nitric acid overnight. All lyophilized extracts
and predigested residue pellets were digested in 250 µL concentrated nitric acid as above and the
final digests were diluted to 5% nitric acid with nanopure water. ICP-MS was preformed using an
8800 Triple Quadrupole ICP-MS (Agilent Technologies, Santa Clara, CA, USA) with a micromist
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nebulizer. Selenium was monitored in MS/MS mode at the second quadrupole as the oxide (SeO,
m/z 96) following collision with oxygen flowing at 50% with integration time of 1 s. Se concentrations
in the digests were calculated from a standard curve of sodium selenite (Na2SeO3) in 5% nitric acid at
5 concentrations from 0.1 to 10 ppm.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-1989/8/3/40/s1,
Figure S1: Higher selenite resistance of A549 or PANC1 spheroids is not due to lower Se accumulation than the
2D counterparts; Figure S2: A549 spheroids respond less to selenite than 2D cultures in terms of morphology,
protein content, mitotic index, and necrosis; Figure S3: PANC1 spheroids respond less to selenite than 2D cultures
in terms of morphology, protein content, mitotic index, and necrosis.; Figure S4: 13C atom-resolved tracing of the
synthesis of 13C2-acetyl CoA and 13C1-isotopologues of Krebs cycle metabolites from 13C6-glucose.
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